about
Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunitiesInitiation to heroin injecting among heroin users in Sydney, Australia: cross sectional surveyPatterns of drug use among a sample of drug users and injecting drug users attending a General Practice in IranEstimated drug overdose deaths averted by North America's first medically-supervised safer injection facilityInjectable and implantable sustained release naltrexone in the treatment of opioid addiction.Non-fatal overdose in the 12 months following treatment for substance use disordersCircumstances surrounding non-fatal opioid overdoses attended by ambulance servicesPolicing and risk of overdose mortality in urban neighborhoodsPreventing opiate overdose deaths: examining objections to take-home naloxone.Gender differences in health related quality of life of young heroin users.Non-fatal overdose and subsequent drug treatment among injection drug users.The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort studyAssociations between childhood trauma and non-fatal overdose among people who inject drugs.Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants.Heroin overdose: research and evidence-based intervention.Comparing injection and non-injection routes of administration for heroin, methamphetamine, and cocaine users in the United States.Characteristics of drug users who witness many overdoses: implications for overdose prevention.High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study.Heroin-related overdose: The unexplored influences of markets, marketing and source-types in the United StatesDrug use patterns predict risk of non-fatal overdose among street-involved youth in a Canadian setting.Prescription opioid use and non-fatal overdose in a cohort of injection drug usersIllicit opioid intoxication: diagnosis and treatment.The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs.The relationship between depressive symptoms and nonfatal overdose among a sample of drug users in Baltimore, Maryland.Attitudes of Emergency Medical Service providers towards naloxone distribution programs.Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug usersDopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levelsNon-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs.Determinants of overdose incidents among illicit opioid users in 5 Canadian cities.Opioid and other substance misuse, overdose risk, and the potential for prevention among a sample of OEF/OIF veterans in New York City.Characteristics of inmates witnessing overdose events in prison: implications for prevention in the correctional settingAre non-fatal opioid overdoses misclassified suicide attempts? Comparing the associated correlatesCan we prevent drug related deaths by training opioid users to recognise and manage overdoses?Circumstances and witness characteristics associated with overdose fatality.Hospitals as a 'risk environment': an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugsAlcohol and drugs in epilepsy: pathophysiology, presentation, possibilities, and prevention.Systematic review of the toxicological and radiological features of body packing.Perceived Severity of and Susceptibility to Overdose Among Injection Drug Users: Relationships With Overdose History.Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program.Performance Measures of Diagnostic Codes for Detecting Opioid Overdose in the Emergency Department.
P2860
Q24678034-8F6FF337-21BA-4A96-8EBA-270E9DCC8963Q24795730-31A03C8F-B850-4577-91CA-A8B0602CB514Q25256595-C5E0A500-5AD4-452C-B0D4-56FA540F8DF9Q28473764-729F75AD-EE05-4CA0-8A48-4F77ED75A446Q33582025-950909A6-DB01-47FB-8DC0-06187CEC4DE2Q33636934-CF102119-96F5-49A7-8AE8-BB99544BC457Q33697978-0CF23949-59B2-492B-914A-D121EE4BC02AQ34432434-246CCD3A-482B-42F2-ADAE-15DDA1C874C2Q34434452-0BAAFFBF-BA3E-4C92-BD3D-C1CFF97FBDDDQ34461495-51FC0C93-E3A1-4BA1-AB21-F51C509D1EA7Q34470475-ACA7549C-E288-4653-8EA4-F0B40629072FQ34582040-03323890-16CB-496C-A8A7-36F7D9878BD1Q35007802-DE33D84F-DFA5-42BB-9099-A6D95DBB5C28Q35146787-A01FC055-A7EE-49F3-B4F4-B4F4C3414A58Q35147553-554644FA-C8D6-45C7-8E55-5A680789A12CQ35575582-5ECA543E-CDD9-47CB-8F53-57108DD5DF9DQ35589591-6C2B9162-7EC2-441C-B076-99AAA880E8A2Q35674947-18870067-57C8-4A08-A8B5-5AD1146A3CDBQ35707238-E9C8ABEF-BA4D-4C47-95E4-4ABBF782768FQ35875932-F376E938-64DB-4CF0-8BA8-4E32F5ACA175Q36072550-725C9B6B-6292-45D9-B8C6-0D7EF585200AQ36138964-956B0F74-7FBB-418E-AE25-99B0CCB38A50Q36248958-FCE35449-CFF3-4629-AEAA-4E8499A069AAQ36273543-168D1775-7497-4857-ADEF-791C266CADA2Q36274283-DBEA7F86-B591-4999-878F-3B6B7CEC34C5Q36733932-2838955A-FE3F-430E-8731-E35D57DE6C43Q36798293-7F534B4D-A7D8-461B-A1C8-A498560E8318Q36803528-B3F1778A-94C0-47A8-8254-279632E031BBQ36988754-B2D35A20-AD1C-47AC-83B5-CF0961B334BEQ37212102-21A2E132-4BCE-4E20-83BD-4967ACCC87DCQ37284016-41C8D9AD-CA66-4E64-A8E2-3CF6BBBD8F55Q37314715-18E7C4DF-872D-4489-B419-7125A977E14DQ37389637-3186993B-AFC1-4EF5-88EB-5DDE1E7DF832Q37390705-822EF59B-FB73-4F2C-B358-7D62C07CE64AQ37633523-8D84A99D-E248-40D0-96DE-C5F13FF86BADQ38040442-33FCB7D0-7F49-4E07-84C2-992CA18FB4F1Q38757241-48FDAC2F-B8BB-43A4-BEBD-6FF0BE31B1D8Q38860304-974E3848-359F-418A-A7CB-53213E06F385Q38882156-2C83BBF0-985D-4241-A999-34D5F8BA9FD5Q38986135-7E7C3779-C3DD-4930-8FCB-E0A9C25E9EB7
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Morbidity associated with non-fatal heroin overdose.
@en
Morbidity associated with non-fatal heroin overdose.
@nl
type
label
Morbidity associated with non-fatal heroin overdose.
@en
Morbidity associated with non-fatal heroin overdose.
@nl
prefLabel
Morbidity associated with non-fatal heroin overdose.
@en
Morbidity associated with non-fatal heroin overdose.
@nl
P2860
P1433
P1476
Morbidity associated with non-fatal heroin overdose.
@en
P2093
Carolyn Day
Matthew Warner-Smith
P2860
P304
P356
10.1046/J.1360-0443.2002.00132.X
P407
P50
P577
2002-08-01T00:00:00Z